| Filed On | Filing |
|---|---|
| 06 Oct 2025 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On October 3, 2025 (the “Grant Date”), the Board of Directors (the “Board”) of the Company approved grants to each of Joshua Silverman, the Company’s Executive Chairman, Christopher Schriber, a director of the Company, Bill White, a dire... |
| 05 Sep 2025 |
8-K/A: Financial Statements and Exhibits
This Technology License and Development Agreement (the “Agreement”) is made and entered into as of September 2, 2025 (subject to Section 10.1, the “Effective Date”), by and among LightSolver Ltd., an Israeli company with its principal pl... |
| 20 Jun 2024 |
8-K/A: Entry into a Material Definitive Agreement
On May 20, 2024, the Company entered into a Securities Purchase Agreement (the “Series G Purchase Agreement”) with certain accredited investors (the “Series G Investors”), pursuant to which it agreed to sell to the Series G Investors (i)... |
| 26 Mar 2024 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year
MyMD Pharmaceuticals, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) hereby certifies: |
| 02 Jul 2021 | 8-K/A: Financial Statements and Exhibits |
| 25 Jan 2021 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 13 Nov 2020 | 8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more |
| 01 Sep 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 02 Nov 2018 | 8-K/A: Entry into a Material Definitive Agreement |
| 12 Oct 2018 | 8-K/A: Departure/Election of Directors or Officers; Compensation; Other Events |
| 05 Jun 2018 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
